Literature DB >> 16882126

Analysis of clinical outcomes and prognostic factors of neoadjuvant chemoradiotherapy combined with surgery: intraperitoneal versus extraperitoneal rectal cancer.

E Benzoni1, G Terrosu, V Bresadola, F Cerato, A Cojutti, E Milan, G Dado, F Bresadola.   

Abstract

Neoadjuvant chemoradiotherapy (CRT) is a widely purposed and performed treatment for rectal cancer. Downstaging effects possibly enhance the rate of curative surgery and may enable sphincter preservation in low-lying tumours. The current study examines the clinical outcomes in patients enrolled in a neoadjuvant CRT-surgery protocol for rectal cancer, distinguishing between intraperitoneal and extraperitoneal cancer. From 1994 to 2003, 58 patients with a primary diagnosis of rectal cancer were enrolled in a single-centre, not randomized study based on 5-week sessions of radiotherapy associated with a 30-day protracted venous 5-FU infusion followed by surgical resection. The study population was divided into two groups according to the localization of the tumour: 18 intraperitoneal and 40 extraperitoneal (EPt). Fifty-eight patients were treated with neoadjuvant CRT and surgery. Overall mortality rate was 25.9%, no deaths were recorded during hospitalization; 10 patients (all EPt) died because of recurrence. Significant differences in disease-free survival and overall survival rates were found between intraperitoneal vs. extraperitoneal tumours (P = 0.006), both intraperitoneal vs. extraperitoneal tumours N(0) (P = 0.04 and P < 0.05) and intraperitoneal vs. extraperitoneal tumours N(+) (P < 0.05). We diagnosed all local recurrence and liver metastasis in extraperitoneal tumours (t = 0.02 and t = 0.04), and only one case of lung metastasis arose from intraperitoneal cancer. Extraperitoneal tumours could be more aggressive than intraperitoneal ones, spreading more precociously, and/or less responsive to the neoadjuvant CRT because of their localization rather than biological differences. Aside from lymph node status, the location of the tumour with respect to the peritoneum border, is also a prognostic factor of survival in rectal cancer treated by neoadjuvant CRT and surgery.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16882126     DOI: 10.1111/j.1365-2354.2006.00653.x

Source DB:  PubMed          Journal:  Eur J Cancer Care (Engl)        ISSN: 0961-5423            Impact factor:   2.520


  7 in total

1.  Oncologic results and prognostic predictors of patients with locally advanced rectal cancer showing ypN0 after radical surgery following neoadjuvant chemoradiotherapy.

Authors:  Kyung-Ha Lee; Jae-Chan Kim; Ji-Yeon Kim; Jin-Su Kim
Journal:  Int J Colorectal Dis       Date:  2015-05-23       Impact factor: 2.571

Review 2.  Magnetic resonance imaging based rectal cancer classification: landmarks and technical standardization.

Authors:  Sami Alasari; Daero Lim; Nam Kyu Kim
Journal:  World J Gastroenterol       Date:  2015-01-14       Impact factor: 5.742

3.  Is rectal MRI beneficial for determining the location of rectal cancer with respect to the peritoneal reflection?

Authors:  Eun Joo Jung; Chun Geun Ryu; Gangmi Kim; Su Ran Kim; Sang Eun Nam; Hee Sun Park; Young Jun Kim; Dae-Yong Hwang
Journal:  Radiol Oncol       Date:  2012-11-09       Impact factor: 2.991

4.  Risk factors of circumferential resection margin involvement in the patients with extraperitoneal rectal cancer.

Authors:  Sung Jin Oh; Jin Yong Shin
Journal:  J Korean Surg Soc       Date:  2012-02-27

5.  Which Definition of Upper Rectal Cancer Is Optimal in Selecting Stage II or III Rectal Cancer Patients to Avoid Postoperative Adjuvant Radiation?

Authors:  Xian Hua Gao; Bai Zhi Zhai; Juan Li; Jean Luc Tshibangu Kabemba; Hai Feng Gong; Chen Guang Bai; Ming Lu Liu; Shao Ting Zhang; Fu Shen; Lian Jie Liu; Wei Zhang
Journal:  Front Oncol       Date:  2021-02-12       Impact factor: 6.244

6.  Recognition of Anterior Peritoneal Reflections and Their Relationship With Rectal Tumors Using Rectal Magnetic Resonance Imaging.

Authors:  Sun Yiqun; Tong Tong; Liu Fangqi; Cai Sanjun; Xin Chao; Gu Yajia; Xu Ye
Journal:  Medicine (Baltimore)       Date:  2016-03       Impact factor: 1.889

7.  Role of adjuvant chemotherapy in locally advanced rectal cancer with ypT0-3N0 after preoperative chemoradiation therapy and surgery.

Authors:  Chang Gon Kim; Joong Bae Ahn; Sang Joon Shin; Seung Hoon Beom; Su Jin Heo; Hyung Soon Park; Jee Hung Kim; Eun Ah Choe; Woong Sub Koom; Hyuk Hur; Byung Soh Min; Nam Kyu Kim; Hoguen Kim; Chan Kim; Inkyung Jung; Minkyu Jung
Journal:  BMC Cancer       Date:  2017-09-02       Impact factor: 4.430

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.